GlassScriptPhysician profile
Seana Dean
NPI 1669448874
$2,212.07
in general payments reported to CMS, 2019-2025
33 companies · $449 in 2025
The $449 reported for 2025 was more than what 92% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $103 · 2021: $199 · 2022: $322 · 2023: $521 · 2024: $485 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,453.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $371.01 | 2020-2025 | |
| Abbott Laboratories | $211.97 | 2022-2025 | Freestyle Libre 3 |
| Supernus Pharmaceuticals, INC. | $170.60 | 2023-2024 | Qelbree, Qelbree |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $155.24 | 2022-2024 | Xifaxan |
| Novo Nordisk INC | $144.86 | 2021-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $102.51 | 2022-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $91.71 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $88.66 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.95 | 2020-2021 | |
| Sanofi Pasteur INC. | $69.53 | 2019-2025 | |
| Exact Sciences Corporation | $64.41 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $57.71 | 2019-2024 | Airsupra |
| Phathom Pharmaceuticals, INC. | $52.60 | 2024-2025 | Voquezna |
| Ironshore Pharmaceuticals INC. | $50.92 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $46.35 | 2022-2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $45.12 | 2022 | |
| Tris Pharma INC | $38.61 | 2025 | Dyanavel Xr |
| Ucb, INC. | $36.79 | 2021 | |
| Sobi, INC | $35.39 | 2019-2023 | |
| Dexcom, INC. | $32.01 | 2022-2024 | Dexcom G6 Transmitter |
| Eisai INC. | $31.43 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $30.94 | 2022 | |
| Paratek Pharmaceuticals, INC. | $30.29 | 2021 | |
| Abbvie INC. | $22.91 | 2025 | |
| Sanofi-Aventis U.S. LLC | $22.52 | 2025 | |
| Sumitomo Pharma America, INC. | $21.79 | 2024 | Gemtesa |
| Biohaven Pharmaceutical Holding Company LTD. | $18.46 | 2022 | |
| Mylan Specialty L.P. | $17.09 | 2024 | Yupelri |
| Lilly USA, LLC | $16.75 | 2023 | Jardiance |
| Vyera Pharmaceuticals, LLC | $12.92 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $12.15 | 2019 | |
| Amgen INC. | $11.86 | 2020 | |
| Vertical Pharmaceuticals, LLC | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seana Dean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.